Key result
The authors provide commentary on a review of Traditional Chinese Medicine for cardiovascular disease, highlighting nonpharmacotherapy, antiarrhythmic RCTs, and active ingredients.
Answers are grounded in this paper and cite their sources.
The authors provide supplementary comments on a review of traditional Chinese medicine for cardiovascular disease, emphasizing nonpharmacotherapies and antiarrhythmic trials.
A review article by Hao et al. ( J Am Coll Cardiol 2017;69(24):2952–66) has had huge repercussions among those familiar with traditional Chinese medicine (TCM) in the international academic community. It evaluated the efficacy and safety of TCM for cardiovascular disease and the pharmacological effect of active TCM ingredients on the cardiovascular system and potential mechanisms. We have several comments: Firstly, we give a brief summary addressing nonpharmacotherapy in TCM, including acupuncture, moxibustion, Qigong, and Tai Chi. Secondly, we have added traditional antiarrhythmic drug–related randomized controlled trials to make the coverage more comprehensive. Lastly, we support the concept that research into, development of, and application of active ingredients is part of modern TCM.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2018) conducted a letter in Cardiovascular disease. Traditional Chinese Medicine was evaluated. The authors provide commentary on a review of Traditional Chinese Medicine for cardiovascular disease, highlighting nonpharmacotherapy, antiarrhythmic RCTs, and active ingredients.
Synapse has enriched 10 related papers. Consider them for comparative context: